보령 3세 김정균 지배력 강화...'제2의 바이젠셀' 투자 속도

Boryung's merger consolidates third-generation management control while strengthening the holding company's financial position and investment capacity. This corporate restructuring enables accelerated venture investments in biotech, following the profitable BioGenCell investment model.